| Title |
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details
|
|---|---|
| Published in |
Modern Rheumatology, September 2011
|
| DOI | 10.1007/s10165-011-0508-6 |
| Pubmed ID | |
| Authors |
Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki, Mitsuhiro Kawano, Motohisa Yamamoto, Takako Saeki, Shoko Matsui, Takayuki Sumida, Tsuneyo Mimori, Yoshiya Tanaka, Kazuo Tsubota, Tadashi Yoshino, Shigeyuki Kawa, Ritsuro Suzuki, Tsutomu Takegami, Naohisa Tomosugi, Nozomu Kurose, Yasuhito Ishigaki, Atsushi Azumi, Masaru Kojima, Shigeo Nakamura, Dai Inoue, The Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team |
| Abstract |
IgG4-related disease (IgG4RD) is a novel clinical disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. IgG4RD may be present in a certain proportion of patients with a wide variety of diseases, including Mikulicz's disease, autoimmune pancreatitis, hypophysitis, Riedel thyroiditis, interstitial pneumonitis, interstitial nephritis, prostatitis, lymphadenopathy, retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pseudotumor. Although IgG4RD forms a distinct, clinically independent disease category and is attracting strong attention as a new clinical entity, many questions and problems still remain to be elucidated, including its pathogenesis, the establishment of diagnostic criteria, and the role of IgG4. Here we describe the concept of IgG4RD and up-to-date information on this emerging disease entity. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 264 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | <1% |
| Germany | 1 | <1% |
| Italy | 1 | <1% |
| Mexico | 1 | <1% |
| Japan | 1 | <1% |
| Unknown | 259 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 49 | 19% |
| Researcher | 35 | 13% |
| Student > Postgraduate | 25 | 9% |
| Student > Ph. D. Student | 21 | 8% |
| Student > Master | 21 | 8% |
| Other | 63 | 24% |
| Unknown | 50 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 151 | 57% |
| Agricultural and Biological Sciences | 15 | 6% |
| Immunology and Microbiology | 12 | 5% |
| Neuroscience | 7 | 3% |
| Biochemistry, Genetics and Molecular Biology | 5 | 2% |
| Other | 15 | 6% |
| Unknown | 59 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2024.
All research outputs
#7,774,000
of 25,363,685 outputs
Outputs from Modern Rheumatology
#149
of 884 outputs
Outputs of similar age
#43,414
of 136,004 outputs
Outputs of similar age from Modern Rheumatology
#2
of 9 outputs
Altmetric has tracked 25,363,685 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 884 research outputs from this source. They receive a mean Attention Score of 2.8. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 136,004 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.